Cytoplasmic chromatin triggers inflammation in senescence and cancer

细胞质染色质在衰老和癌症中引发炎症

阅读:8
作者:Zhixun Dou ,Kanad Ghosh ,Maria Grazia Vizioli ,Jiajun Zhu ,Payel Sen ,Kirk J Wangensteen ,Johayra Simithy ,Yemin Lan ,Yanping Lin ,Zhuo Zhou ,Brian C Capell ,Caiyue Xu ,Mingang Xu ,Julia E Kieckhaefer ,Tianying Jiang ,Michal Shoshkes-Carmel ,K M Ahasan Al Tanim ,Glen N Barber ,John T Seykora ,Sarah E Millar ,Klaus H Kaestner ,Benjamin A Garcia ,Peter D Adams ,Shelley L Berger

Abstract

Chromatin is traditionally viewed as a nuclear entity that regulates gene expression and silencing. However, we recently discovered the presence of cytoplasmic chromatin fragments that pinch off from intact nuclei of primary cells during senescence, a form of terminal cell-cycle arrest associated with pro-inflammatory responses. The functional significance of chromatin in the cytoplasm is unclear. Here we show that cytoplasmic chromatin activates the innate immunity cytosolic DNA-sensing cGAS-STING (cyclic GMP-AMP synthase linked to stimulator of interferon genes) pathway, leading both to short-term inflammation to restrain activated oncogenes and to chronic inflammation that associates with tissue destruction and cancer. The cytoplasmic chromatin-cGAS-STING pathway promotes the senescence-associated secretory phenotype in primary human cells and in mice. Mice deficient in STING show impaired immuno-surveillance of oncogenic RAS and reduced tissue inflammation upon ionizing radiation. Furthermore, this pathway is activated in cancer cells, and correlates with pro-inflammatory gene expression in human cancers. Overall, our findings indicate that genomic DNA serves as a reservoir to initiate a pro-inflammatory pathway in the cytoplasm in senescence and cancer. Targeting the cytoplasmic chromatin-mediated pathway may hold promise in treating inflammation-related disorders.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。